HomeBBLG • NASDAQ
add
Bone Biologics Corp
Previous close
$1.41
Day range
$1.42 - $1.61
Year range
$1.31 - $8.16
Market cap
2.46M USD
Avg Volume
35.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 715.27K | -24.79% |
Net income | -666.74K | 29.15% |
Net profit margin | — | — |
Earnings per share | -0.37 | 97.40% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.05M | 69.61% |
Total assets | 6.35M | 56.20% |
Total liabilities | 334.28K | 22.27% |
Total equity | 6.02M | — |
Shares outstanding | 1.80M | — |
Price to book | 0.42 | — |
Return on assets | -26.78% | — |
Return on capital | -28.36% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -666.74K | 29.15% |
Cash from operations | -591.38K | -3.36% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -591.38K | -147.91% |
Free cash flow | -458.87K | -88.46% |
About
Founded
2004
Headquarters
Website
Employees
2
